Self-reports are not related to objective assessments of cognitive function and sedation in patients with cancer pain admitted to palliative care unit

Palliative Medicine

Volumn 16, Issue 6, 2002, Pages 513-519

  Klepstad, Pål ^a   Hilton, Priscilla ^a   Moen, Jorunn ^a   Fougner, Bjørn ^a   Borchgrevink, Petter C ^b   Kaasa, Stein ^c  

^a Unit for Applied Clinical Research   (Norway)

^b Dept of Environmental Medicine ^*  (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Assessment; Cancer; Cognitive function; Morphine; Sedation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CORTICOSTEROID; MORPHINE; NEUROLEPTIC AGENT; PARACETAMOL;

ADULT; AGED; ALERTNESS; ARTICLE; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL OBSERVATION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; FATIGUE; FEMALE; HOSPITAL ADMISSION; HUMAN; MALE; MEDICAL ASSESSMENT; MEMORY CONSOLIDATION; MENTAL CONCENTRATION; MENTAL HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SEDATION; SELF REPORT; VERBAL BEHAVIOR;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; COGNITION; CONSCIOUSNESS; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MORPHINE; NEOPLASMS; PAIN; PALLIATIVE CARE; PROSPECTIVE STUDIES;

EID: 0036438972     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/0269216302pm587oa     Document Type: Article

References (21)

1. Bruera E, Miller L, McCallion J, Macmillan K, Krefting L, Hanson J. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 1992; 7: 192-95.
2. O'Neill WM. The cognitive and psychomotor effects of opioid drugs in cancer pain management. Cancer Surv 1994; 21: 67-84.
3. Bruera E, Neuman CM. Opioid toxicities - assessment and management. In Max M ed. Pain 1999 - an updated review, first edition. Seattle: IASP Press, 1999: 443-57.
4. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 2001; 19: 2542-54.
5. Klepstad P, Borchgrevink PC, Kaasa S. Effects on cancer patients' health-related quality of life after the start of morphine therapy. J Pain Symptom Manage 2000; 20: 19-26.
6. Jordhøy MS, Fayers P, Saltnes T, Ahlner-Elmquist M, Jannert M, Kaasa S. A palliative-care intervention and death a home: a cluster randomised trial. Lancet 2000; 356: 888-93.
7. Cull A, Hay C, Love SB, Mackie M, Smets E, Stewart M. What do cancer patients mean when they complain of concentration and memory problems. Br J Cancer 1996; 74: 1674-79.
8. Taber's medical dictionary, eighteenth edition. Philadelphia: F.A. Davies, 1997.
9. Chernic DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 1990; 10: 244-51.
10. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
11. Fayers P, Aaronson NK, Bjordal K, Sullivan M. EORTC QLQ-C30 scoring manual. Brussels: EORTC Study Group on Quality of Life, 1995.
12. Kaasa S, Bjordal K, Aaronson N, et al. The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 1995; 31A: 2260-63.
13. Jensen Hjermstad M, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249-54.
14. Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-98.
15. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
16. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993; 37: 147-53.
17. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-56.
18. Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained release oral morphine in cancer pain: preference, efficacy, and quality of life. J Pain Symptom Manage 1997; 13: 254-61.
19. Wisløff F, Eika S, Hippe E, et al. Measurement of health-related quality of life in multiple myeloma. Br J Heamatol 1996; 92: 604-13.
20. Radbruch L, Sabatowski R, Loick G, et al. Cognitive impairment and its influence on pain and symptom assessment in a palliative care unit: development of a minimal documentation system. Palliat Med 2000; 14: 266-76.
21. Joffe S, Cook EF, Cleary PD, Clarck JW, Weeks JC. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001; 358: 1772-77.